All Pharma News
Statera Biopharma gets the OK to resume the study of a potential stockpile drug

Statera Biopharma gets the OK to resume the study of a potential stockpile drug
Nicole DeFeudis ENDPTS
02 Dec 2021
Share Share
Cytocom to Become Statera BioPharma

Cytocom to Become Statera BioPharma
CONTRACT PHARMA
01 Sep 2021
Share Share
Cytocom to Become Statera BioPharma

Cytocom to Become Statera BioPharma
CONTRACT PHARMA
31 Aug 2021
Share Share
Cytocom, Inc. Reports Second Quarter 2021 Financial Results

Cytocom, Inc. Reports Second Quarter 2021 Financial Results
PR NEWSWIRE
16 Aug 2021
Share Share
Cytocom to fund laboratory facilities at La Jolla Institute for Immunology

Cytocom to fund laboratory facilities at La Jolla Institute for Immunology
PHARMABIZ
14 Aug 2021
Share Share
Cytocom to Fund Research and Lab Facilities at the La Jolla Institute

Cytocom to Fund Research and Lab Facilities at the La Jolla Institute
CONTRACT PHARMA
13 Aug 2021
Share Share
Cytocom, Inc. and La Jolla Institute for Immunology Announce Agreement

Cytocom, Inc. and La Jolla Institute for Immunology Announce Agreement
PRNEWSWIRE
12 Aug 2021
Share Share
Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs
PRNEWSWIRE
05 Aug 2021
Share Share
Cleveland and Cytocom Announce Registration Statement and Proxy Statement

Cleveland and Cytocom Announce Registration Statement and Proxy Statement
BIOSPACE
17 Jun 2021
Share Share
Cytocom Receives FDA Clearance of IND for Phase 2 Clinical Trial of CYTO-205

Cytocom Receives FDA Clearance of IND for Phase 2 Clinical Trial of CYTO-205
PRNEWSWIRE
16 Mar 2021
Share Share